1-O-myristoylglycerol-2,3-cyclic phosphorodithioate

has antineoplastic activity; structure in first source

Also Known As:

Myr-2S-cPA

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Bujacz, Anna: 1 article (01/2016)
2.	Ciesielska, Anna: 1 article (01/2016)
3.	Koziołkiewicz, Maria: 1 article (01/2016)
4.	Rytczak, Przemyslaw: 1 article (01/2016)
5.	Sekula, Bartosz: 1 article (01/2016)

1.	Neoplasms (Cancer) 01/01/2016 - "Myr-2S-cPA reduces cancer cell viability in a dose-dependent manner, with IC50 value of 29.0 μM after 24 h incubation, which is almost 30% lower than IC50 of single substituted phosphorothioate cPA. "